Botanical species · safety record

Platycladus orientalis

The EFSA Compendium of Botanicals holds 13 constituent measurements for Platycladus orientalis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Platycladus orientalis (L.) Franco

13Constituent measurements

0Safety records

5Cited sources

233Licensed products (Canada)

Also recorded as

Thuja orientalis L.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 233 licensed products naming Platycladus orientalis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
decoction
solid

Source material stated

Dried seed(s)
Fruit
Kernel
Kernel (stir-fried)
Leaf
Leaf and twig
Leaf and twig of the flower
Leaf/Leaves

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-camphor	Aerial part of plants	Essential oil	2.3 Percent	GC-MS	Resolve DOI
Alpha-cedrol	Stem / stalk	Essential oil	6.1 Percent	GC-MS	Resolve DOI
Alpha-cedrol	Leaves	Essential oil	11.3 Percent	GC-MS	Resolve DOI
Alpha-thujone	Aerial part of plants	Essential oil	52.28 Percent	GC-MS	Resolve DOI
Beta-thujone	Aerial part of plants	Essential oil	10.3 Percent	GC-MS	Resolve DOI
Fenchone	Aerial part of plants	Essential oil	12.25 Percent	GC-MS	Resolve DOI
Labdane diterpenes	Leaves	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Labdane diterpenes	Seed	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Myrcene	Leaves	Essential oil	1.5 Percent	GC-MS	Resolve DOI
Myrcene	Stem / stalk	Essential oil	3.6 Percent	GC-MS	Resolve DOI
Alpha-cedrol	Leaves	Essential oil	14.9 Percent	GC-MS	No resolvable identifier
Alpha-cedrol	Fruit unspecified	Essential oil	6.9 Percent	GC-MS	No resolvable identifier
Myrcene	Fruit unspecified	Essential oil	3.8 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Kim, Min-Gi., Lee, Hoi-Seon. Growth-inhibiting effects and chemical composition of essential oils extracted from Platycladus orientalis leaves and stems toward human intestinal bacteria . Food science and biotechnology, 2015, vol. 24, no. 2, p. 427-431. DOI
Hashemi, Seyed Mehdi., Safavi, Seyed Ali. CHEMICAL CONSTITUENTS AND TOXICITY OF ESSENTIAL OILS OF ORIENTAL ARBORVITAE, Platycladus orientalis (L.) FRANCO, AGAINST THREE STORED-PRODUCT BEETLES . Chilean journal of agricultural research, 2012, vol. 72, no. 2, p. 188-194.
Kim, Jin-Young., Kim, Hyun Jung., Kim, Sung-Moo., Park, Kyung-Ran., Jang, Hyeung-Jin., Lee, Eun Ha., Jung, Sang Hoon., Ahn, Kwang Seok. Methylene chloride fraction of the leaves of Thuja orientalis inhibits in vitro inflammatory biomarkers by blocking NF-kappa B and p38 MAPK signaling and protects mice from lethal endotoxemia . Journal of ethnopharmacology, 2011, vol. 133, no. 2, p. 687-695. DOI
Ren, X. -Y., Ye, Y. Labdane diterpenes from the seeds of Platycladus orientalis. Journal of asian natural products research, 2006, vol. 8, no. 8, p. 677-682. DOI
Chizzola, R., Hochsteiner, W., Hajek, S. GC analysis of essential oils in the rumen fluid after incubation of Thuja orientalis twigs in the Rusitec system . Research in veterinary science, 2004, vol. 76, no. 1, p. 77-82. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature